Document is current

Article History

Received: 19 February 2025

Accepted: 18 March 2025

First Online: 15 April 2025

Declarations

:

: Linda Stein Gold is an investigator, consultant, and/or speaker for Abbvie, Arcutis, Amgen, Dermavant, Galderma, Incyte, LEO Pharma, Lilly, Pfizer, Regeneron, and Sanofi. Andrew Alexis is an investigator, consultant, and/or speaker for AbbVie, Amgen, LEO Pharma, Galderma, Arcutis, Dermavant, Castle, Incyte, Pfizer, Sanofi-Regeneron, Genzyme, Beiersdorf, Ortho, L’Oreal, Bristol Myers Squibb, Bausch Health, UCB, Janssen, Allergan, Almirall, VisualDx, Eli Lilly and Company, Swiss American, Cutera, Cara Therapeutics, EPI, Incyte, Castle, Apogee, Canfield Scientific, Alphyn Biologics, Avita Medical, Genentech, Boehringer Ingelheim, Johnson and Johnson, Aerolase, Springer, Wiley-Blackwell, Wolters Kluwer Health, and Elsevier. Brad Glick is an investigator, consultant, speaker, and/or stakeholder for AbbVie, Amgen, Arcutis, AstraZeneca, Bellus Medical, Brickell Biotech, Bristol Myers Squibb, Cara Therapeutics, ChemoCentryx, CorEvitas Registry PSO, CorEvitas Registry AD, Dermavant, Dermira, Eli Lilly and Company, Galderma, Incyte, Janssen, LEO Pharma, Nimbus Lakshmi, Novartis, Ortho, Pfizer, PROSE Registry for AD, Regeneron, Sanofi-Genzyme, Sun Pharmaceutical Industries, Top MD, and UCB. Mona Shahriari is an investigator, consultant, and/or speaker for AbbVie, Amgen, Apogee, Arcutis, Bristol Myers Squibb, Cara Therapeutics, CorEvitas Registry PSO, CorEvitas Registry AD, Dermavant, Dermira, Galderma, Incyte, Janssen, LEO Pharma, Lilly USA, Mindera Health, Novartis, Pfizer, Sanofi-Genzyme, Regeneron, UCB, and Union Therapeutics. Eingun James Song is an investigator, consultant, and/or speaker for AbbVie, Alphyn Biologics, Amgen, Apogee, Arcutis, Bristol Myers Squibb, Boehringer Ingelheim, Dermavant, DermBiont, Galderma, Incyte, Janssen, LEO Pharma, MoonLake, Novartis, Ortho, Pfizer, Regeneron, Sanofi, Sun Pharmaceutical Industries, Timber Pharmaceuticals, and UCB. Bruce Strober is an investigator, consultant, speaker, and/or stockholder for AbbVie, Alumis, Almirall, Amgen, Arcutis, Boehringer Ingelheim, Bristol Myers Squibb, Capital One, Connect Biopharma, CorEvitas Registry PSO, Dermavant, Janssen, LEO Pharma, Eli Lilly and Company, Mindera Health, Maruho, Meiji Seika Pharma, Novartis, Oruka Therapeutics, Protagonist, Pfizer, Rapt, Regeneron, Sanofi-Genzyme, SG Cowen, Takeda, UCB, Union Therapeutics. Najat M. Watch and Melodie Young report no conflicts of interest.

: All experts who took part in this conference are the authors of this manuscript, therefore ethical approval was not required.